Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R0.6C vaccine in healthy malaria-naïve adults
NCT04862416Phase 1Completed
- Sponsor
- Radboud University Medical Center
- Start
- May 2021
- Primary completion
- Jun 2022
- Modality
- Vaccines & Immunotherapeutics, Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 1, open-label trial of R0.6C vaccine in malaria, sponsored by Radboud University Medical Center. Started May 2021; status: completed.
02
Drugs
R0.6C vaccine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT04862416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04862416.